Cash & equivalents increased 245.8%
Cash & equivalents changed +245.8% from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Cash & equivalents changed +245.8% from the comparable as-filed period.
Inventory changed +29.0% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Net income changed -365.0% from the comparable as-filed period.
Operating income changed -25.6% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Operating margin changed -10881 basis points from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Revenue changed -27.3% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Selling, general & administrative changed +68.2% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Stock-based compensation changed +1018.4% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Research & development changed +14.4% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.